In 2012, Sequana Medical launched the alfapump system during the International Liver Congress, the largest annual gathering of hepatologists worldwide.
Sales for 2012 exceeded CHF 1 million. Also in 2012 the Company initiated a multi-centre European Randomized Trial in patients with ascites caused by liver disease, and received CE-mark approval for the removal of ascites caused by cancer.